David Aaron Lehman - Mar 1, 2023 Form 4 Insider Report for Pulmonx Corp (LUNG)

Role
General Counsel
Signature
/s/ Lauren Cristina, Attorney-in-Fact for David Lehman
Stock symbol
LUNG
Transactions as of
Mar 1, 2023
Transactions value $
-$13,942
Form type
4
Date filed
3/3/2023, 06:00 PM
Previous filing
Dec 5, 2022
Next filing
Jun 2, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LUNG Common Stock Sale -$5.05K -458 -1.04% $11.03 43.7K Mar 1, 2023 Direct F1
transaction LUNG Common Stock Sale -$8.89K -806 -1.84% $11.03 42.9K Mar 1, 2023 Direct F2
transaction LUNG Common Stock Award $0 +118K +275.78% $0.00 161K Mar 1, 2023 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LUNG Employee Stock Option (right to buy) Award $0 +81K $0.00 81K Mar 1, 2023 Common Stock 81K $11.48 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on June 1, 2021.
F2 These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on March 1, 2022.
F3 Represents grant of Restricted Stock Units payable solely in common stock of the Issuer that vest over four years in equal quarterly installments beginning on March 1, 2023.
F4 The shares subject to the option vest in 48 equal monthly installments beginning on March 1, 2023.